Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Shiying Dang"'
Autor:
Yang Leng, Shiying Dang, Fei Yin, Tianshun Gao, Xing Xiao, Yi Zhang, Lin Chen, Changfei Qin, Nannan Lai, Xiao-Yong Zhan, Ke Huang, Chuanming Luo, Yang Kang, Nan Wang, Yun Li, Yuhong Liang, Bihui Huang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Lung cancer is one of the most common and mortal malignancies, usually with a poor prognosis in its advanced or recurrent stages. Recently, immune checkpoint inhibitors (ICIs) immunotherapy has revolutionized the treatment of human cancers including
Externí odkaz:
https://doaj.org/article/4a97346112594053aa9bd0069a3294fe
Autor:
Honghua Peng, Guifeng Liu, Ying Bao, Xi Zhang, Lehong Zhou, Chenghui Huang, Zewen Song, Sudan Cao, Shiying Dang, Jing Zhang, Tanxiao Huang, Yuling Wu, Mingyan Xu, Lele Song, Peiguo Cao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundRadical or palliative surgery with subsequent adjuvant therapy is the routine treatment for stage II/III colorectal cancer(CRC) and some stage IV CRC patients. This study aimed to clarify the prognostic clinicopathological and genetic facto
Externí odkaz:
https://doaj.org/article/0a9f4053f9e54c838efd1c4559ec0d27
Autor:
Yayi He, Lele Song, Hao Wang, Peixin Chen, Yu Liu, Hui Sun, Xiaobin Li, Shiying Dang, Guifeng Liu, Xinyi Liu, Shifu Chen, Xiaoni Zhang, Paul Hofman, Junji Uchino, Henry S. Park, Jose M. Pacheco, Fabrizio Tabbò, Mingyan Xu, Jiawei Dai, Kan He, Yang Yang, Caicun Zhou, written on behalf of the AME Lung Cancer Collaborative Group
Publikováno v:
Advanced Science, Vol 8, Iss 4, Pp n/a-n/a (2021)
Abstract Evaluating the therapeutic response and survival of lung cancer patients receiving first‐line chemotherapy has always been difficult. Limited biomarkers for evaluation exist and as a result histology represents an empiric tool to guide the
Externí odkaz:
https://doaj.org/article/4017226be18d4378aff7e04ce9660858
Autor:
Jinbing Li, Yuhang Li, Xiao-Yong Zhan, Xinru Ran, Hung-Fat Tse, Shiying Dang, Yichu Nie, Ke Huang
Publikováno v:
Stem Cell Research, Vol 49, Iss , Pp 102090- (2020)
GADD45A is a DNA damage and stressful growth arrest inducible protein, also it is shown to a be tumor suppressor gene and a chromatin relaxer associated with opening chromatin during the somatic reprogramming. However, its role in human embryonic ste
Externí odkaz:
https://doaj.org/article/7944617ae5eb494aa9f3703e1bd3f83d
Autor:
Helmut Popper, Haoyue Guo, Bo Zhu, Shifu Chen, Ming Liu, Lishu Zhao, Guifeng Liu, Yayi He, Patrick C. Ma, Shiying Dang, Mingyan Xu, Shinji Sasada, Xiaoni Zhang, Nico van Zandwijk, Caicun Zhou, Hao Wang, Linsong Chen, Xinyi Liu, Minlin Jiang, Rafael Rosell
Publikováno v:
Theranostics
Background: Recent studies in non-small cell lung cancer (NSCLC) patients have demonstrated that first-line immunotherapy is associated with better therapeutic response than second-line treatment. So far, the mechanisms need to be explored. It prompt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08974b5b5e67a4363e4b131ea60ac264
https://doi.org/10.7150/thno.58039
https://doi.org/10.7150/thno.58039
Autor:
Shiying Dang, Lin Chen, Xiao-Yong Zhan, Fei Yin, Ke Huang, Yun Li, Yang Kang, Yuhong Liang, Nan Wang, Tianshun Gao, Xing Xiao, Yi Zhang, Bihui Huang, Nannan Lai, Changfei Qin, Chuanming Luo, Yang Leng
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Lung cancer is one of the most common and mortal malignancies, usually with a poor prognosis in its advanced or recurrent stages. Recently, immune checkpoint inhibitors (ICIs) immunotherapy has revolutionized the treatment of human cancers including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f044491275c7996ec90f1fca5fa7718b
http://europepmc.org/articles/PMC8713481
http://europepmc.org/articles/PMC8713481
Autor:
Honghua Peng, Guifeng Liu, Ying Bao, Xi Zhang, Lehong Zhou, Chenghui Huang, Zewen Song, Sudan Cao, Shiying Dang, Jing Zhang, Tanxiao Huang, Yuling Wu, Mingyan Xu, Lele Song, Peiguo Cao
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundRadical or palliative surgery with subsequent adjuvant therapy is the routine treatment for stage II/III colorectal cancer(CRC) and some stage IV CRC patients. This study aimed to clarify the prognostic clinicopathological and genetic facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4cacbd6fc0480f359ec3d3de80c395c
https://pubmed.ncbi.nlm.nih.gov/34993129
https://pubmed.ncbi.nlm.nih.gov/34993129
Autor:
Lifeng Li, Jianfei Yao, Yuan Gong, Tanxiao Huang, Xiumei Peng, Shifu Chen, Yuemin Li, Lele Song, Wei Zhao, Guifeng Liu, Shaohua Guo, Shiying Dang, Wenhua Xiao, Zhifeng Han, Hongyi Liu
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
POLE/POLD1 gene variants have been suggested as potential markers for immunotherapy due to their significant association with the tumor mutational burden (TMB), an effective indicator for response prediction in immunotherapy. However, the correlation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839dd5ce45e0036fde0a754f26477273
https://doi.org/10.1038/s41598-019-52414-z
https://doi.org/10.1038/s41598-019-52414-z
Autor:
Yayi He, Linsong Chen, Lishu Zhao, Shiying Dang, Guifeng Liu, Shinji Sasada, Ma, Patrick C., van Zandwijk, Nico, Rosell, Rafael, Popper, Helmut H., Hao Wang, Minlin Jiang, Haoyue Guo, Xinyi Liu, Shifu Chen, Xiaoni Zhang, Mingyan Xu, Bo Zhu, Ming Liu, Caicun Zhou
Publikováno v:
Theranostics; 2021, Vol. 11 Issue 14, p7092-7109, 18p
Autor:
Yuhang Li, Ke Huang, Xiao-Yong Zhan, Xinru Ran, Jinbing Li, Hung-Fat Tse, Shiying Dang, Yichu Nie
Publikováno v:
Stem Cell Research, Vol 49, Iss, Pp 102090-(2020)
PARP1 encodes a chromatin-associated enzyme which responsible for post-translational poly(ADP-ribosyl)ation modification (Hsieh et al., 2017). It plays an important role in nucleotide excision repair, non-homologous end joining, DNA mismatch repair a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5396b550beb292466218dab93a3954d
https://doi.org/10.1016/j.scr.2020.102090
https://doi.org/10.1016/j.scr.2020.102090